Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/40/74/2e/40742e6c-6a61-2d95-b634-8dda4a9dba7b/mza_13147460199252821216.jpg/600x600bb.jpg

LifeSci Partners Podcast

LifeSci Partners.com

74 episodes

1 week ago

This podcast series, sponsored by LifeSci Partners, brings the listener right into the mindset, and motivations of some of the top players in the healthcare biotechnology industry.

Life Sciences

Science

RSS

All content for LifeSci Partners Podcast is the property of LifeSci Partners.com and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

This podcast series, sponsored by LifeSci Partners, brings the listener right into the mindset, and motivations of some of the top players in the healthcare biotechnology industry.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/12716813/12716813-1696340796727-b5c9694899d6e.jpg

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

LifeSci Partners Podcast

41 minutes

2 years ago

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Tune into Episode #2 of the LifeSci Search podcast with Andy Cronin (President & Co-Founder) and Ayesha Price (Sr. Director, Executive Search) as they host Iris Grossman (Chief Therapeutics Officer, Eleven Therapeutics) and Shahram Ebadollahi (Operating Partner, ARCHIMED & Former Chief Data Officer, Novartis) on the topic of AI and ML tools in Drug R&D. We get insights on how the tech is being leveraged in biotech and pharma along the R&D process, overall impact so far, thinking around AI and ML among leadership teams & boards, and perspectives on the competition for AI and ML talent within Life Sciences industry.